<?xml version="1.0" encoding="UTF-8"?>
<p id="para0029">Glycyrrhizin is the chief constituent of 
 <italic>Glycyrrhiza glabra</italic> root and are rich in flavonoids, β-sitosterol, hydroxyl coumarins and glycyrrhetinic acid. Glycyrrhizin, since the ancient times have been employed in treatment of various ailments including bronchitis, gastritis and jaundice. Furthermore, they have been affirmed to have anti-inflammatory and antioxidant potential that induce the formation of interferons in human body (
 <xref rid="bib0190" ref-type="bibr">Ramos-Tovar et al., 2020</xref>). It was observed by 
 <xref rid="bib0183" ref-type="bibr">Pilcher (2003)</xref> that Glycyrrhizin lowers the ability of SARS-Cov agents to attach to the cell particularly in the early stages of viral infestation. Similar, observation of imperative anti-SARS-CoV activity as shown by Glycyrrhizin was made by 
 <xref rid="bib0042" ref-type="bibr">Cinatl et al. (2003)</xref>. The anti-SARS-CoV activity of Glycyrrhizin was further confirmed by other studies (
 <xref rid="bib0257" ref-type="bibr">Yeh et al. 2013</xref>). More recently, the in-silico experimentation revealed that Glycyrrhizin has similar behaviour against COVID-19 disease and acts as a potential inhibitor (
 <xref rid="bib0157" ref-type="bibr">Mohammadi and Shaghaghi, 2020</xref>).
</p>
